Cytozyme Laboratories, Inc., a Verdesian Life Sciences company, recently achieved the renewal of ISO/IEC 17025: 2017 Accreditation in Chemical Testing for its Analytical Laboratory in South Salt Lake City, Utah. This accreditation was presented on June 10th on behalf of A2LA, an independent, internationally recognized accreditation body.
ISO/IEC 17025 accreditation is recognized by the industry as one of the most important standards. It specifies broad requirements for a laboratory’s competence to produce precise, accurate test and calibration data. The standard consists of general, structural, resource, process, and management system requirements, including:
- traceability of measurements and calibrations to national standards;
- technical competence of staff;
- maintenance of test equipment;
- quality assurance of test and calibration data;
- validity and appropriateness of test methods;
- appropriate handling and transportation of test items; and
- quality of testing environment and sampling.
This accreditation demonstrates “technical competence for a defined scope and the operation of a laboratory quality management system.”
“This accreditation is a testament to high standards that we set here at Verdesian Life Sciences,” says Dr. Kuide Qin, Chief Science Officer, Verdesian Life Sciences. “This certificate further helps us toward global recognition, consistent operations, and brings a competitive advantage.”
Established in 1978 as a public service membership society, A2LA is dedicated to the formal recognition of competent testing and calibration laboratories (including medical laboratories), biobanking facilities, inspection bodies, product certification bodies, proficiency testing providers, and reference material producers. A2LA has over 3700 actively accredited certificates representing all 50 US states and more than 50 countries.
Matt Lail, APR
Director, Marketing Communications & Public Relations